CTIX - Cellceutix Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CTIX - Cellceutix Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: jmhollen	8/18/2009 12:18:39 PM
	of 106

Cellceutix Corp executes manufacturing agreement for Kevetrin API Aug. 18, 2009 (M2 Communications Ltd.) -- Biopharmaceutical company Cellceutix Corp (OTCBB:CTIX) said on Monday that the company has entered into an agreement for the manufacture of Kevetrin active pharmaceutical ingredient to treat certain cancers. The agreement, terms of which have not been disclosed, has been signed with Girindus America Inc. The company has recently reported encouraging results in animal models of drug resistant lung cancers. Cellceutix will use the material for toxicology studies, for filing of an IND and Phase 1 human trials. .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next